Board approves Q1 FY27 results, MD re-appointment and new auditor appointments

Revenue Growth 20pctPat Growth 25pctResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+10.7%Reaction day

₹5.40

prior close

₹5.40

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%+10.4% vs market

Auto Components & Equipments peers, median of 117sector-0.1%+10.8% vs sector

On the reaction day the stock moved 10.4 pts more than Nifty Microcap 250 and 10.8 pts more than its Auto Components & Equipments peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+5.6

10m

+9.3

15m

+9.3

30m

+9.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+10.7+0.4+10.4-0.1+10.8

Next day

+12.2+0.5+11.7-0.5+12.7

+9.3+0.6+8.7-0.3+9.6

+3.1+0.7+2.4-0.2+3.3

+3.9+1.1+2.8+0.3+3.5

+1.9+0.5+1.3-0.3+2.2

+4.4+1.3+3.2-0.2+4.7

15d

+1.9+0.5+1.3-2.3+4.1

+3.7-0.8+4.5-4.2+7.9

+5.4-0.9+6.3-3.6+8.9

—————

UpDownMarket · Nifty Microcap 250Sector · Auto Components & Equipments peers, median of 117Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

AMFORGE INDUSTRIES board approved Q1 FY27 (June 2026) unaudited results. Total income rose to Rs. 98.72 lakhs from Rs. 49.57 lakhs year-on-year, nearly doubling. Net profit stood at Rs. 36.97 lakhs versus a loss of Rs. 4.17 lakhs in Q1 FY26. EPS was Rs. 0.26. Mr. Jayesh Thakkar re-appointed as Managing Director for 3 years from May 24, 2027. New Secretarial and Internal Auditors also appointed for FY27.

Likely market impact

Strong quarter with revenue nearly doubling and a swing to profit. MD continuity confirmed for 3 more years.